Skip to main content
FogPharma Logo
  • About
  • Science
  • Pipeline
  • Culture & Careers
  • News
Back

Endpoints: Harvard’s Gregory Verdine has big ambitions for his miniprotein ‘braces’ — and now $107M to guide them to the clinic

03/01/2021

Read more https://endpts.com/harvards-gregory-verdine-has-big-ambitions-for-his-miniprotein-braces-and-now-107m-to-guide-them-to-the-clinic/

FogPharma Logo
LinkedIn
Contact Us
  • Privacy Policy
  • Terms & Conditions

2023© FogPharma